Skip to Content
Cartwright & Cline Nutrition LLC
Work with Me
Lab Testing
Shop
Self Paced Classes
About
Consult
Contact
Login Account
0
0
Cartwright & Cline Nutrition LLC
Work with Me
Lab Testing
Shop
Self Paced Classes
About
Consult
Contact
Login Account
0
0
Work with Me
Lab Testing
Shop
Self Paced Classes
About
Consult
Contact
Login Account
Shop StoolOMX GI-Map (Add on)
Unknown.jpeg Image 1 of
Unknown.jpeg
Unknown.jpeg

StoolOMX GI-Map (Add on)

$98.32

If you have purchased the GI-Map and want to dig deeper, you can add the StoolOMX test which evaluates 25 bile acids (total concentrations, percentages, and ratios) and 9 short chain fatty acids (SCFAs), offering clinicians valuable insights into gut functionality. Bile acids and SCFAs play critical roles in digestion, motility, microbiome balance, and metabolic health. Imbalances in these metabolites can drive conditions such as IBS, IBD, bile acid diarrhea, and altered gut motility.

Recent studies show that up to 30% of patients with IBS-D are affected by bile acid diarrhea, underscoring the importance of evaluating bile acids in clinical practice. Further, bile acid malabsorption is associated with irritable bowel syndrome and inflammatory bowel disease. StoolOMX is a comprehensive bile acid test that helps elucidate bile acid malabsorption so practitioners can more precisely identify the root causes of these prevalent gut disorders.

Bile acids are produced by the liver from cholesterol and play a critical role in fat digestion. The liver synthesizes primary bile acids and conjugates them to enhance solubility. These bile acids are stored in the gallbladder and released into the small intestine during meals to emulsify and absorb dietary fats.

Under normal conditions, most primary bile acids are reabsorbed, with minimal amounts excreted in stool. Primary bile acids are metabolized by gut bacteria to become secondary bile acids. In abnormal cases of excess production, bile acid malabsorption (BAM), or gut dysfunction, excess bile acids enter the colon, potentially causing inflammation and diarrhea.

Results from the StoolOMX bile acids test add-on to the GI-MAP can help identify underlying issues contributing to conditions such as:

  • Bile Acid Diarrhea (BAD)

  • Irritable Bowel Syndrome (IBS)(-C, -D, -M)

  • Inflammatory Bowel Disease (IBD)

StoolOMX sets a new standard in bile acid testing by leveraging advanced technology to measure more bile acids than anyone else in the industry, delivering unmatched precision in totals, percentages, and ratios for superior clinical insights.

Balanced SCFA production reflects optimal fiber fermentation, a balanced microbiome, and a healthy gut barrier. High branched chain fatty acids (BCFAs) indicate excess proteolytic/putrefactive fermentation, which can promote inflammation. StoolOMX reports on each short chain fatty acid and provides a SCFA/BCFA ratio, which offers insight into diet, root causes of symptoms of constipation and diarrhea, and more.

Low or imbalanced SCFA levels or an altered SCFA/BCFA ratio may indicate:

  • Insufficiency Dysbiosis or lack of microbial diversity

  • Inflammatory Dysbiosis

  • Leaky gut syndrome

  • Constipation or diarrhea

  • Poor diet quality

Quantity:
Add To Cart

If you have purchased the GI-Map and want to dig deeper, you can add the StoolOMX test which evaluates 25 bile acids (total concentrations, percentages, and ratios) and 9 short chain fatty acids (SCFAs), offering clinicians valuable insights into gut functionality. Bile acids and SCFAs play critical roles in digestion, motility, microbiome balance, and metabolic health. Imbalances in these metabolites can drive conditions such as IBS, IBD, bile acid diarrhea, and altered gut motility.

Recent studies show that up to 30% of patients with IBS-D are affected by bile acid diarrhea, underscoring the importance of evaluating bile acids in clinical practice. Further, bile acid malabsorption is associated with irritable bowel syndrome and inflammatory bowel disease. StoolOMX is a comprehensive bile acid test that helps elucidate bile acid malabsorption so practitioners can more precisely identify the root causes of these prevalent gut disorders.

Bile acids are produced by the liver from cholesterol and play a critical role in fat digestion. The liver synthesizes primary bile acids and conjugates them to enhance solubility. These bile acids are stored in the gallbladder and released into the small intestine during meals to emulsify and absorb dietary fats.

Under normal conditions, most primary bile acids are reabsorbed, with minimal amounts excreted in stool. Primary bile acids are metabolized by gut bacteria to become secondary bile acids. In abnormal cases of excess production, bile acid malabsorption (BAM), or gut dysfunction, excess bile acids enter the colon, potentially causing inflammation and diarrhea.

Results from the StoolOMX bile acids test add-on to the GI-MAP can help identify underlying issues contributing to conditions such as:

  • Bile Acid Diarrhea (BAD)

  • Irritable Bowel Syndrome (IBS)(-C, -D, -M)

  • Inflammatory Bowel Disease (IBD)

StoolOMX sets a new standard in bile acid testing by leveraging advanced technology to measure more bile acids than anyone else in the industry, delivering unmatched precision in totals, percentages, and ratios for superior clinical insights.

Balanced SCFA production reflects optimal fiber fermentation, a balanced microbiome, and a healthy gut barrier. High branched chain fatty acids (BCFAs) indicate excess proteolytic/putrefactive fermentation, which can promote inflammation. StoolOMX reports on each short chain fatty acid and provides a SCFA/BCFA ratio, which offers insight into diet, root causes of symptoms of constipation and diarrhea, and more.

Low or imbalanced SCFA levels or an altered SCFA/BCFA ratio may indicate:

  • Insufficiency Dysbiosis or lack of microbial diversity

  • Inflammatory Dysbiosis

  • Leaky gut syndrome

  • Constipation or diarrhea

  • Poor diet quality

If you have purchased the GI-Map and want to dig deeper, you can add the StoolOMX test which evaluates 25 bile acids (total concentrations, percentages, and ratios) and 9 short chain fatty acids (SCFAs), offering clinicians valuable insights into gut functionality. Bile acids and SCFAs play critical roles in digestion, motility, microbiome balance, and metabolic health. Imbalances in these metabolites can drive conditions such as IBS, IBD, bile acid diarrhea, and altered gut motility.

Recent studies show that up to 30% of patients with IBS-D are affected by bile acid diarrhea, underscoring the importance of evaluating bile acids in clinical practice. Further, bile acid malabsorption is associated with irritable bowel syndrome and inflammatory bowel disease. StoolOMX is a comprehensive bile acid test that helps elucidate bile acid malabsorption so practitioners can more precisely identify the root causes of these prevalent gut disorders.

Bile acids are produced by the liver from cholesterol and play a critical role in fat digestion. The liver synthesizes primary bile acids and conjugates them to enhance solubility. These bile acids are stored in the gallbladder and released into the small intestine during meals to emulsify and absorb dietary fats.

Under normal conditions, most primary bile acids are reabsorbed, with minimal amounts excreted in stool. Primary bile acids are metabolized by gut bacteria to become secondary bile acids. In abnormal cases of excess production, bile acid malabsorption (BAM), or gut dysfunction, excess bile acids enter the colon, potentially causing inflammation and diarrhea.

Results from the StoolOMX bile acids test add-on to the GI-MAP can help identify underlying issues contributing to conditions such as:

  • Bile Acid Diarrhea (BAD)

  • Irritable Bowel Syndrome (IBS)(-C, -D, -M)

  • Inflammatory Bowel Disease (IBD)

StoolOMX sets a new standard in bile acid testing by leveraging advanced technology to measure more bile acids than anyone else in the industry, delivering unmatched precision in totals, percentages, and ratios for superior clinical insights.

Balanced SCFA production reflects optimal fiber fermentation, a balanced microbiome, and a healthy gut barrier. High branched chain fatty acids (BCFAs) indicate excess proteolytic/putrefactive fermentation, which can promote inflammation. StoolOMX reports on each short chain fatty acid and provides a SCFA/BCFA ratio, which offers insight into diet, root causes of symptoms of constipation and diarrhea, and more.

Low or imbalanced SCFA levels or an altered SCFA/BCFA ratio may indicate:

  • Insufficiency Dysbiosis or lack of microbial diversity

  • Inflammatory Dysbiosis

  • Leaky gut syndrome

  • Constipation or diarrhea

  • Poor diet quality